全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Federico Biscetti , Elisabetta Nardella , Nicola Bonadia ...
来源:[J].Cardiovascular Diabetology(IF 4.209), 2019, Vol.18 (1), pp.1-7DOAJ
摘要:... Several studies have documented a correlation between omentin-1 serum levels, atherosclerosis, and cardiovascular diseases. However, a clear link between circulating omentin-1 and PAD in diabetic patients has yet to be established. The aim of this study was to investigate th...
作者:Yu Du , Qingwei Ji , Lun Cai ...
来源:[J].Cardiovascular Diabetology(IF 4.209), 2016, Vol.15 (1)Springer
摘要:Abstract(#br) Background(#br)Omentin-1, a novel adipocytokine mainly expressed in visceral adipose tissue, has been found to inhibit the inflammatory response and improve insulin resistance as well as other obesity-related disorders. This study investigated the association betw...
作者:Luigi Brunetti , Sheila Leone , Giustino Orlando ...
来源:[J].Pharmacological Reports(IF 1.965), 2014, Vol.66 (6), pp.991-995Elsevier
摘要:...(#br)Methods(#br)We investigated, in normotensive rats, the effects of subacute omentin-1 administration [8 μg/kg, intraperitoneally ( ip ), once daily for 14 days] on cardiac activity, blood pressure, plasma concentration of l -citrulline (as a marker of NO production from...
作者:Nejmeddine Ouerghi , Mohamed Kacem Ben Fradj , Ikram Bezrati ...
来源:[J].Obesity Facts(IF 1.583), 2017, Vol.10 (4), pp.323-331DOAJ
摘要:Objectives: Omentin-1 is a recently discovered adipokine, mainly produced by visceral adipose tissue, which is thought to improve insulin sensitivity. The study aimed to assess the association of plasma omentin-1 with cardiometabolic traits and physical performance and to test...
作者:Gillian Barker , Ratana Lim , Harry M Georgiou ...
来源:[J].PLoS ONE(IF 3.73), 2018, Vol.7 (8)DOAJ
摘要:The aim of this study was to determine (i) the effect of maternal obesity and gestational diabetes mellitus (GDM) on (i) the circulating levels of omentin-1 in cord and maternal plasma, and (ii) gene expression and release of omentin-1 from human placenta and adipose tissue. The ...
作者:Cymbaluk-Płoska A , Chudecka-Głaz A , Jagodzińska A ...
来源:[J].OncoTargets and Therapy(IF 2.073), 2018, Vol.Volume 11, pp.1363-1372DOAJ
摘要:... Aims: To consider the role that four adipokines – leptin, omentin-1, vaspin, and galectin-3 – play in the diagnosis of endometrium cancer and to investigate the association between serum concentrations of adipose tissue metabolism products and the diagnostics and pro...
作者:Li Yin , Dan Huang , Xinxin Liu ...
来源:[J].Stem Cell Research & Therapy(IF 3.652), 2017, Vol.8 (1)Springer
摘要:... Omentin-1, a new fat depot-specific secretory adipokine, exerts proproliferation, prosurvival, and proangiogenic functions in certain cells via an Akt-dependent mechanism; however, little is known about the influence of omentin-1 on MSCs.
作者:Hye Jin Yoo , Soon Young Hwang , Ho Cheol Hong ...
来源:[J].Cardiovascular Diabetology(IF 4.209), 2011, Vol.10 (1)Springer
摘要:... Omentin-1 is a recently discovered novel adipokine, so data about the relationship of this adipokine to vascular health in type 2 diabetes is limited.(#br) Methods(#br)We enrolled 60 people with type 2 diabetes, with or without carotid plaque, and 30 participants with normal ...
作者:Sabrina Greulich , Weena J Y Chen , Bujar Maxhera ...
来源:[J].PLoS ONE(IF 3.73), 2017, Vol.8 (3)DOAJ
摘要:... In DM2-patients, circulating levels of omentin-1, an adipokine preferentially expressed in epicardial adipose tissue, are decreased. This study investigated whether omentin-1 has a cardioprotective function. METHODS: Omentin-1 levels in plasma and cardiac fat depots were dete...
作者:Citlalli E. Hernández-Rodríguez , Cynthia M. Estrada-Zúñiga , Manuel E. De la O-Cavazos ...
来源:[J].Early Human Development(IF 2.02), 2019, Vol.139Elsevier
摘要:... Omentin-1 is an adipokine that has been shown in vitro to possibly be involved in insulin sensitivity modulation. The prenatal stage is a crucial period for development of metabolic diseases in the long term, therefore, small (SGA) and large (LGA) for gestational age newbor...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×